Compare RYOJ & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYOJ | CCEL |
|---|---|---|
| Founded | 2015 | 1989 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Managed Health Care |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.8M | 35.8M |
| IPO Year | 2025 | 1997 |
| Metric | RYOJ | CCEL |
|---|---|---|
| Price | $4.03 | $3.99 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 71.7K | 3.8K |
| Earning Date | 12-19-2025 | 10-15-2025 |
| Dividend Yield | N/A | ★ 10.03% |
| EPS Growth | ★ 72.91 | N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | $11,576,848.00 | ★ $31,747,500.00 |
| Revenue This Year | N/A | $0.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $30.25 | ★ N/A |
| Revenue Growth | ★ 5.60 | N/A |
| 52 Week Low | $1.81 | $3.57 |
| 52 Week High | $11.43 | $8.86 |
| Indicator | RYOJ | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 45.97 |
| Support Level | N/A | $4.04 |
| Resistance Level | N/A | $4.08 |
| Average True Range (ATR) | 0.00 | 0.18 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 47.95 |
rYojbaba Co Ltd is engaged in improving and restoring physical and mental health diminished by work-related stress through consulting and health services. The company provides consulting services to labor unions and companies wishing to build constructive relationships with labor unions and health services to osteopathic clinics and osteopathic beauty salons to alleviate physical ailments created by work-related stress.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.